BRCA1 and breast carcinoma: BAP1, originally identified as an associated protein of the breast cancer susceptibility gene product BRCA1, is a nuclear deubiquitinase with ubiquitin carboxy-terminal hydrolase activity and contributes to the inhibition of E3 ligase function of BRCA1/BRAD during DNA damage response (13) (Figure 1B).